Allogene's newly hired general counsel Earl Douglas said he was drawn to the South San Francisco-based company's "deep commitment to scientific innovation, experience and leadership."
August 15, 2023 at 02:45 PM
3 minute read
The original version of this story was published on Corporate Counsel
Allogene Therapeutics, a clinical-stage biotech working on cancer-fighting T-cell therapies, recruited seasoned startup lawyer Earl Douglas as general counsel.
Douglas has a rich background in the biotech startup world. He was most recently executive vice president and general counsel of Applied Molecular Transport, a biopharmaceutical company developing treatments for severe autoimmune, metabolic and inflammatory diseases.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Earl Douglas, general counsel at Allogene Therapeutics. Courtesy photo
